skip to Main Content

Moving from pre-clinical to clinical-stage

IBT CEO Dr. M. Javad Aman will discuss the development of a multi-component toxoid vaccine for S. aureus and the regulatory challenges and opportunities when moving a product from pre-clinical to clinical stage. The live webinar scheduled for Sept. 24, 2020 will feature experts on various aspects of antimicrobial resistance (AMR) who will share their knowledge and opinions the current state of the AMR R&D field.

Register for Live Webinar Sept. 24, 2020 9:30-11:30AM

Haimi Shiferaw
Back To Top